Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Marksans Pharma has informed that the Company has scheduled a conference call for analysts and investors on Friday, November 14, 2025 at 05:00 PM (IST) to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2025. The details and schedule with respect to the conference call are enclosed. The presentation along with the audio recording of the call and the transcript will be hosted on the Company’s website at https://www.marksanspharma.com/earnings-call-transcripts.html.
The above information is a part of company’s filings submitted to BSE.
